MAPT and Alzheimer disease: Extensive tau phosphorylation at various amino acid residues converts soluble tau proteins into PHF leading to the development of NFTs, which cause tau pathologies in AD and other tauopathies (Grundke-Iqbal et al., 1986; Kosik et al., 1986; Brion et al., 1991).